Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
2.530
-0.230 (-8.33%)
At close: Aug 11, 2025, 4:00 PM
2.560
+0.030 (1.19%)
After-hours: Aug 11, 2025, 4:00 PM EDT

Paramount Global Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
-0.2533.494.932-
Upgrade
Revenue Growth (YoY)
--99.25%579.21%146.30%--
Upgrade
Gross Profit
-0.2533.494.932-
Upgrade
Selling, General & Admin
19.8317.2113.9120.7812.864.43
Upgrade
Research & Development
61.7550.3350.2543.9842.4113.85
Upgrade
Operating Expenses
81.5867.5364.1664.7655.2718.27
Upgrade
Operating Income
-81.58-67.28-30.67-59.83-53.27-18.27
Upgrade
Interest Expense
------0.2
Upgrade
Interest & Investment Income
7.455.352.541.29-0
Upgrade
Other Non Operating Income (Expenses)
-3.34-5.78-0.97-0.2-18.550.48
Upgrade
EBT Excluding Unusual Items
-77.47-67.72-29.1-58.74-71.83-17.99
Upgrade
Gain (Loss) on Sale of Investments
2.342.340.46---
Upgrade
Pretax Income
-75.13-65.37-28.65-58.74-71.83-17.99
Upgrade
Income Tax Expense
--0.070.05--
Upgrade
Net Income
-75.13-65.37-28.72-58.79-71.83-17.99
Upgrade
Net Income to Common
-75.13-65.37-28.72-58.79-71.83-17.99
Upgrade
Shares Outstanding (Basic)
23111111
Upgrade
Shares Outstanding (Diluted)
23111111
Upgrade
Shares Change (YoY)
2746.19%1302.54%4.70%11.80%8.60%3.59%
Upgrade
EPS (Basic)
-3.26-5.81-35.78-76.67-104.73-28.49
Upgrade
EPS (Diluted)
-3.26-5.81-35.78-76.67-104.73-28.49
Upgrade
Free Cash Flow
-70.81-55.67-50.69-57.13-17.03-13.83
Upgrade
Free Cash Flow Per Share
-3.07-4.95-63.14-74.51-24.83-21.89
Upgrade
Gross Margin
-100.00%100.00%100.00%100.00%-
Upgrade
Operating Margin
--26805.58%-91.58%-1213.32%-2660.94%-
Upgrade
Profit Margin
--26045.02%-85.75%-1192.21%-3587.66%-
Upgrade
Free Cash Flow Margin
--22180.88%-151.34%-1158.55%-850.55%-
Upgrade
EBITDA
-79.07-64.85-28.41-58.67-53.02-18.2
Upgrade
EBITDA Margin
---84.81%---
Upgrade
D&A For EBITDA
2.512.432.271.160.250.07
Upgrade
EBIT
-81.58-67.28-30.67-59.83-53.27-18.27
Upgrade
EBIT Margin
---91.58%---
Upgrade
Revenue as Reported
0.250.2533.494.93--
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q